Barbara Menzaghi
Overview
Explore the profile of Barbara Menzaghi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
65
Citations
494
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Testa J, Cattaneo D, Giacomelli A, Lai A, Ridolfo A, Gori A, et al.
AIDS
. 2025 Mar;
39(5):625-626.
PMID: 40080172
No abstract available.
2.
Ferrario L, Menzaghi B, Rizzardini G, Roccia A, Garagiola E, Bellavia D, et al.
Glob Reg Health Technol Assess
. 2025 Mar;
12:49-60.
PMID: 40027177
No abstract available.
3.
Formenti B, Benoni R, Testa J, Bertoli G, Stroffolini G, Pizzi M, et al.
J Migr Health
. 2025 Feb;
11:100307.
PMID: 39990239
Viral hepatitis is a leading cause of mortality and a global public health challenge that, until recently, has been largely neglected as a health priority. This study describes the prevalence...
4.
Ferrario L, Menzaghi B, Rizzardini G, Roccia A, Garagiola E, Bellavia D, et al.
Pharmacoecon Open
. 2025 Jan;
9(2):327.
PMID: 39853521
No abstract available.
5.
Lucrezia F, Ferrario L, Menzaghi B, Barbara M, Rizzardini G, Giuliano R, et al.
Pharmacoecon Open
. 2024 Nov;
9(2):313-326.
PMID: 39532817
Objective: The aim of this study was to define the economic and organizational impacts related to a broader utilization of bictegravir/emtricitabine/alafenamide (BIC/FTC/TAF) in Italian clinical practice. Methods: A budget impact...
6.
De Socio G, Ricci E, Piconi S, Squillace N, Maggi P, Orofino G, et al.
AIDS
. 2024 Oct;
39(2):143-152.
PMID: 39434586
Objective: The study aimed to assess the impact of smoking exposure on major clinical events (MCEs) in a real-life setting of people with HIV (PWH). Design: An observational, longitudinal, multicenter...
7.
Mazzitelli M, Pontillo D, Clemente T, Di Biagio A, Cenderello G, Rusconi S, et al.
J Antimicrob Chemother
. 2024 Jul;
79(9):2163-2169.
PMID: 39001781
Objectives: To evaluate polypharmacy, anticholinergic burden (ACB) and drug-drug interactions (DDIs) in people with four-class-resistant HIV (4DR-PWH). Methods: We performed a cross-sectional study, including 4DR-PWH from the PRESTIGIO Registry taking...
8.
Corti N, Menzaghi B, Orofino G, Guastavigna M, Lagi F, Di Biagio A, et al.
Viruses
. 2024 Apr;
16(4).
PMID: 38675955
Cardiovascular disease (CVD) is common in people with HIV (PWH), and has great impact in terms of morbidity and mortality. Several intertwined mechanisms are believed to play a role in...
9.
Colpani A, De Vito A, Zauli B, Menzaghi B, Calcagno A, Celesia B, et al.
Healthcare (Basel)
. 2024 Feb;
12(4).
PMID: 38391793
Poor knowledge of sexually transmitted infections (STIs) and HIV among people with HIV (PLHIV) could worsen life quality. We aimed to investigate their STI and HIV knowledge, disclosure and undetectable...
10.
Papaioannu Borjesson R, Galli L, Lolatto R, Menzaghi B, Feasi M, Gulminetti R, et al.
AIDS
. 2024 Feb;
38(3):435-438.
PMID: 38300163
No abstract available.